Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Curran

Showing results (921-930 of 965) with videos related to

Pageof 97
Sort By:
Scientific Reports|January 6, 2017
Antarctic ice sheet discharge driven by atmosphere-ocean feedbacks at the Last Glacial TerminationC J Fogwill, C S M Turney, N R Golledge, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine CoreTao Yu, Jayaram R Tagat, Angela D Kerekes, et al.
Blood Advances|February 5, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignanciesSanam Shahid, Susan E Prockop, Georgia C Flynn, et al.
The New England Journal of Medicine|February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastomaMark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Advances in Radiation Oncology|March 18, 2021
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysisRoshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Blood Advances|June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantationRoni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
JCO Clinical Cancer Informatics|December 6, 2023
Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation OncologyDanielle S Bitterman, Michael F Gensheimer, David Jaffray, et al.
Blood|October 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P Margossian, Nancy A Kernan, et al.
Blood Advances|November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantationMadhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
Pageof 97

Showing results (921-930 of 965) with videos related to

Sort By:
Pageof 97
Scientific Reports|January 6, 2017
Antarctic ice sheet discharge driven by atmosphere-ocean feedbacks at the Last Glacial TerminationC J Fogwill, C S M Turney, N R Golledge, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine CoreTao Yu, Jayaram R Tagat, Angela D Kerekes, et al.
Blood Advances|February 5, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignanciesSanam Shahid, Susan E Prockop, Georgia C Flynn, et al.
The New England Journal of Medicine|February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastomaMark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Advances in Radiation Oncology|March 18, 2021
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysisRoshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Blood Advances|June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantationRoni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
JCO Clinical Cancer Informatics|December 6, 2023
Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation OncologyDanielle S Bitterman, Michael F Gensheimer, David Jaffray, et al.
Blood|October 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P Margossian, Nancy A Kernan, et al.
Blood Advances|November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantationMadhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
Pageof 97